Structure Therapeutics Inc.
GPCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001888886
No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.
Holders of 5% or more of GPCR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Structure Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 13G/A | 11.90%20.6M shares | +2.00 ppfrom 9.90% | Aug 12, 20253 filings | Nov 7, 2025 | SEC |
| FMR LLC | 13G/A | 11.60%19.9M shares | – | Aug 6, 20251 filing | Aug 6, 2025 | SEC |
| Avoro Capital Advisors LLC | 13G | 9.38%16.2M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 7.70%4.45M shares | −0.30 ppfrom 8.00% | Feb 14, 20254 filings | Nov 14, 2025 | SEC |
| Deep Track Capital, LP | 13G/A | 7.32%12.6M shares | −1.60 ppfrom 8.92% | Jan 13, 20254 filings | Nov 14, 2025 | SEC |
| Biotechnology Value Fund L P | 13G | 5.60%9.61M shares | New | Aug 18, 20251 filing | Aug 18, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Structure Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 202512:07 PM ET | Janus Henderson Group PLC | 13G/A | 7.70%4.45M shares | −0.30 ppfrom 8.00% | Sep 30, 2025 | SEC |
| Nov 14, 20259:01 AM ET | Avoro Capital Advisors LLCand 1 other | 13G | 9.38%16.2M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20258:15 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 7.32%12.6M shares | −1.60 ppfrom 8.92% | Sep 30, 2025 | SEC |
| Nov 7, 20258:18 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 11.90%20.6M shares | +2.00 ppfrom 9.90% | Oct 31, 2025 | SEC |
| Nov 7, 20258:16 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 9.90%17.1M shares | −2.10 ppfrom 12.00% | Sep 30, 2025 | SEC |
| Aug 18, 20255:02 PM ET | Biotechnology Value Fund L Pand 9 others | 13G | 5.60%9.61M shares | New | Aug 11, 2025 | SEC |
| Aug 14, 202511:26 AM ET | Janus Henderson Group PLC | 13G/A | 8.00%4.57M shares | +0.40 ppfrom 7.60% | Jun 30, 2025 | SEC |
| Aug 14, 20258:46 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.92%15.4M shares | +1.77 ppfrom 7.15% | Jun 30, 2025 | SEC |
| Aug 12, 202511:20 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 12.00%20.6M shares | – | Jun 30, 2025 | SEC |
| Aug 6, 202512:14 PM ET | FMR LLCand 1 other | 13G/A | 11.60%19.9M shares | – | Jun 30, 2025 | SEC |
| May 15, 20258:42 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 7.15%12.3M shares | +1.91 ppfrom 5.24% | Mar 31, 2025 | SEC |
| May 14, 202512:32 PM ET | Janus Henderson Group PLC | 13G/A | 7.60%4.36M shares | +0.30 ppfrom 7.30% | Mar 31, 2025 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G/A | 3.80%6.49M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 202512:22 PM ET | Janus Henderson Group PLC | 13G/A | 7.30%4.16M shares | – | Dec 31, 2024 | SEC |
| Jan 13, 20254:08 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.24%9.00M shares | New | Jan 6, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Structure Therapeutics Inc. shares.
No Form 144 notices for Structure Therapeutics Inc. are on file.